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Objectives:  It is  well  known  that sex  differences  in analgesic  prescription  are  not  merely  the  logical
result  of  greater  prevalence  of  pain  in  women,  since  this  therapeutic  variability  is  related  to  factors
such  as  educational  level  or social  class.  This  study  aims  to analyse  the  relationship  between  analgesic
prescription  and  gender  development  in different  regions  of Spain.
Methods:  Cross-sectional  study  of  sex-differences  in analgesic  prescription  according  to  the  gender devel-
opment of  the regions  studied.  Analgesic  prescription,  pain  and demographic  variables  were  obtained
from  the Spanish  Health  Interview  Survey  in  2006.  Gender  development  was  measured  with  the  Gender
Development  Index  (GDI).  A logistic  regression  analysis  was  conducted  to  compare  analgesic  prescription
by sex  in regions  with  a GDI  above  or below  the  Spanish  average.
Results:  Once  adjusted  by  pain,  age  and  social  class,  women  were  more  likely  to be  prescribed  analgesics
than  men,  odds  ratio  (OR)  = 1.74  (1.59-1.91),  as residents  in regions  with  a lower  GDI  compared  with  those
in region  with  a higher  GDI:  ORWomen = 1.26 (1.12-1.42),  ORMen =  1.30  (1.13-1.50).  Women  experiencing
pain in regions  with  a  lower  GDI  were  more  likely  than  men  to be  treated  by  a general  practitioner  rather
than by  a specialist,  OR  = 1.32 (1.04-1.67),  irrespective  of age  and  social  class.
Conclusions:  Gender  bias  may  be one  of  the  pathways  by which  inequalities  in  analgesic  treatment
adversely  affect  women’s  health.  Moreover,  research  into  the  adequacy  of  analgesic  treatment  and  the
possible medicalisation  of women  should  consider  contextual  factors,  such  as  gender  development.
©  2011  SESPAS.  Published  by  Elsevier  España,  S.L.  All rights  reserved.
Desigualdad  en  prescripción  de  analgésicos  en  Espan˜a.  Una  cuestión
de  desarrollo  de  género
alabras clave:
esarrollo de género
iferencias por sexo
nalgésicos
r  e  s  u  m  e  n
Objetivos:  Las  diferencias  por  sexo  en  la  prescripción  de analgésicos  no  son  simplemente  el  resultado
lógico  de  una  mayor  prevalencia  del  dolor  en  las  mujeres  (ya  que  se relaciona  con  factores  como  la
educación  o la clase  social).  El  objetivo  de  este  estudio  fue  analizar  la  relación  entre  la  prescripción  de
analgésicos  y  el  desarrollo  de  género  de  las  regiones  de Espan˜a.
Métodos:  Estudio  transversal  de  las  diferencias  por  sexo  en  la prescripción  de  analgésicos  en función  del
desarrollo  de  género  de  las  regiones.  La  prescripción  de  analgésicos,  el  dolor  y las  variables  demográﬁcas
se  obtuvieron  de  la  Encuesta  Nacional  de  Salud  de 2006.  El  desarrollo  de  género  se  midió  con  el  Índice  de
Desarrollo  al Género  (IDG).  Se realizó  un  análisis  de  regresión  logística  para  comparar  la prescripción  de
analgésicos  por  sexo  en  las  regiones  con  IDG  mayor  o menor  que  la media  espan˜ola.
Resultados:  Independientemente  del dolor,  la  edad  y la  clase  social,  las  mujeres  tienen  mayor  probabilidad
de  prescripción  de analgesia  que los hombres,  con una  odds  ratio  (OR)  = 1,74  (1,59-1,91),  así  como  los
residentes  de  las  regiones  con  menor  IDG en  comparación  con  los  de regiones  con  mayor  IDG: ORMujeres
=  1,26  (1,12-1,42),  ORHombres = 1,30  (1,13-1,50).  Las mujeres  que  padecen  dolor  en regiones  de  menor
IDG  tienen  más  probabilidades  de ser  tratadas  por  un  médico  y no por un  especialista,  con una  OR  = 1,32
(1,04-1,67).
Conclusiones:  El  sesgo  de género  puede  ser  una  vía  por  la  cual  las  desigualdades  en  el tratamiento
analgésico  afecta  negativamente  a la  salud  de  las  mujeres.  La  investigación  sobre  la conveniencia  de
la analgesia  y la  medicalización  de  las  mujeres  debería  incluir  factores  de  contexto,  como  el  desarrollo
de género.© 2011  S
∗ Corresponding author.
E-mail address: elisa.chilet@ua.es (E. Chilet-Rosell).
213-9111/$ – see front matter © 2011 SESPAS. Published by Elsevier España, S.L. All righ
ttp://dx.doi.org/10.1016/j.gaceta.2012.04.014ESPAS.  Publicado  por  Elsevier  España,  S.L.  Todos  los  derechos  reservados.
ts reserved.
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Consistent with the greater prevalence of pain in women, epi-
emiological studies have shown that they report a signiﬁcantly
igher use of analgesics than men.1,2 Accordingly, pain should log-
cally be the main reason for analgesic prescription. However, the
iterature indicates that given the same pain intensity, women
re more likely to be prescribed analgesics.3 Furthermore, for the
ame intensity, men  are prescribed more aggressive treatment (for
xample, opioid-analgesia for men  versus non-opioid analgesia
or women).4 It is important to determine whether this differ-
nce is explained by adequate drug use or whether women  are
nnecessarily exposed to a much greater risk of adverse effects
nd dependency as they are more frequently prescribed with
nalgesics.5
It was during the 1990s that empirical evidence began to emerge
egarding the possibly inappropriate treatment of women  as a
esult of gender bias, indicating differential management of men
nd women with the same health problem.6 Of particular note are
he gender bias studies related to the treatment of cardiovascu-
ar disease.7 At that time, much of the gender bias in health care
ould be explained by insufﬁcient knowledge of this issue. How-
ver, given the amount of evidence published in the literature
oday, lack of knowledge can no longer explain the persistence of
his problem.7 Furthermore, women’s lack of access to specialist
ervices and the symptomatic treatment they receive imply that
he cause of the problem is being overlooked.8,9
The therapeutic variability associated with the sex of patients
xperiencing pain is related not only to individual factors, such as
arital status, educational level and lifestyle,1,10 but also to fac-
ors linked to social inequalities such as ethnic group and social
lass.11,12 A study conducted by Kawachi et al.13 highlights the
mportance of gender inequalities for the social determinants of
ealth and demonstrates the association with social status for
omen and morbidity for both sexes, according to geographic
egion within the same country. More recently, the ﬁnal report
f Sen et al.14 for the WHO  Commission on Social Determinants
f Health indicates that gender inequality undermines the physi-
al and mental health of millions of girls and women worldwide, as
ell as that of boys and men. Furthermore, the association between
he empowerment of women and community health indicators
as been demonstrated,15 based particularly on the woman’s role
s the primary caregiver within the family. Nevertheless, further
esearch is necessary to determine which speciﬁc aspects of the
mpowerment of women effectively inﬂuence the health of the
arger community.15
The Gender Development Index (GDI), created in 1995 by the
nited Nations, is the Human Development Index that differenti-
tes the development of women and men  as regards life expectancy
t birth, as well as two important health determinants: educa-
ion and income.16 Recent studies have shown that clear regional
nequalities exist within Spain.17 Historically, northern regions
ave enjoyed greater economic and gender development18 which,
ccording to the literature cited above, suggests that analgesic pre-
cription may  be subject to gender bias in southern regions of Spain.
he existence of gender bias in analgesic treatment poses some
dditional problems since national health services were created
o reduce inequalities and to provide free services to all citizens
egardless of their ethnic group, social class or gender.19 In these
quity-based systems, discrimination against over half the popula-
ion — women— has more explicit political implications.
The literature on differential analgesic prescription for men  and
omen has not focused to date on contextual determinants such
s human development according to region of residence. Based
n the Spanish National Health Survey 2006/2007, the aim of this
tudy was to analyse factors associated with analgesic prescriptionit. 2013;27(2):135–142
according to levels of gender development in Spain, considering
pain, age and social class.
Methods
Design and source of data
We used individualised secondary data collected during the
Spanish National Health Survey carried out in 2006 and 200720
which was  conducted by the Spanish Statistics Institute under the
aegis of the Ministry of Health and Social Policy. The format of this
survey was  adapted to meet the requirements of the guidelines
for the development and criteria for the adoption of Health Survey
instruments proposed by the European Commission.21 The survey
covered a representative sample of Spain’s non-institutionalised
population residing in main family dwellings (households) and, in
order to meet its aim of being able to furnish estimates with a cer-
tain degree of reliability at national and regional levels, a sample of
29,478 households was  selected. Study subjects were selected by
means of probabilistic multistage sampling, in which the ﬁrst-stage
units were the census sections, and the second-stage units were
main family dwellings. Information was collected in home-based
personal interviews. The methodology is described elsewhere.20 A
total of 29,478 adults (individuals aged at least 16 years old) of
both sexes (14,459 men  and 15,019 women) living in Spain were
interviewed.
Using the data collected, this study presents a nationwide,
descriptive, cross-sectional epidemiologic study of analgesic pre-
scription.
Variables
The dichotomous dependent variable chosen was  the answer
“yes” or “no” to the question “In the last two weeks, have you taken
any pain medication prescribed to you by a doctor?”
The independent variables collected in the study were primary
socio-demographic characteristics such as age (divided into three
categories: 16-44, 45-64, ≥65 years), sex and occupational status,
which was  used as a proxy variable of social class (manual/non
manual).22
The variable pain conﬁrmed by a doctor was created based on
the answers to questions about different types of pain: “has a doc-
tor conﬁrmed that you are experiencing neck pain, lumbar pain or
frequent headaches/migraine in the last 12 months?” We  consid-
ered the answer afﬁrmative if the interviewee answered “yes” to
having being diagnosed with at least one of these types of pain.
The independent variable medical consultation was  classiﬁed
as dichotomous: consulting a general practitioner (people who
answered that they had visited a general practitioner once or more
in the last four weeks, and who  had not seen a specialist) and see-
ing a specialist (people who  responded that they had consulted a
specialist once or more). This variable was created from two ques-
tions: “how many times have you visited a general practitioner
in the last 4 weeks due to a complaint or a disease?” and “how
many times have you consulted a specialist?” Although it was  not
possible to establish whether pain was the reason for visiting the
general practitioner or specialist, this variable was only calculated
for those subjects with pain diagnosed by a doctor and prescribed
an analgesic. No reason for medical consultation was excluded.
With the aim of identifying gender inequalities within a coun-
try, province or region, the UN proposed the GDI. The GDI has been
used to measure gender inequalities in health, as it includes life
expectancy by sex as well as two determinants of health: educa-
tional level and purchasing power parity.16
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Gender development is measured by calculating GDI values
0: low gender development index – 1: high gender development
ndex). The GDI is the average of three sub-indices: the equally
istributed life expectancy index, the equally distributed educa-
ion index and the equally distributed income index, measured by
he gross domestic product per capita, expressed as equally dis-
ributed purchasing power parity in US dollars.23 For this study,
e used a dichotomous classiﬁcation of the 2005 GDI for the differ-
nt regions in Spain: below national average in Spain (Andalusia,
sturias, the Canary Islands, Castile-La Mancha, Region of Valen-
ia, Extremadura, Galicia, Murcia) or above (Aragon, the Balearic
slands, Cantabria, Castile and León, Catalonia, Madrid, Navarre, the
asque Country, La Rioja), based on previous work published in
etail by our research team.18
This classiﬁcation showed a north-south pattern whereby gen-
er development in northern regions of Spain is above the national
verage whilst in the south it is lower.
In order to express the dimension and direction of the differ-
nce that exists between men  and women in analgesic prescription,
he gender gap was calculated as the difference between the per-
entage of analgesic prescription for women and men, and it was
tandardised by dividing this difference by the sum of both per-
entages.
tatistical analysis
Analgesic prescription patterns for women and men  for the year
006 were stratiﬁed by age, social class, the GDI for the area of
esidence in Spain, diagnosis of pain by a doctor and consultation
ith a general practitioner or a specialist. The 2 test and a contrast
f proportional equality were used to determine the signiﬁcance of
ifferences between men  and women.
To estimate the independent effect of sex on analgesic pre-
cription, a non-conditional logistic regression model was used.
e calculated the odds ratio (OR) and conﬁdence intervals of
5% (CI95%), adjusted for pain conﬁrmed by a doctor, age and
ocial class. We  also calculated the association between analgesic
rescription and sex for the different social classes (adjusted for
ge and pain) and for different age groups (adjusted for social class
nd pain). The same analysis was conducted for regions with a GDI
bove or below the Spanish average. Furthermore, the probability
f analgesic prescription for men  was calculated according to the
DI for their area of residence and for the different social classes
nd age groups, as it was for women.
In order to determine general practitioner and specialist con-
ultation patterns according to sex for those individuals who
esponded in the afﬁrmative to the question regarding pain con-
rmed by a doctor in the last 12 months, raw probability was
alculated, together with probability adjusted for age and social
lass. The same analysis was conducted for regions with a GDI above
r below the Spanish average.
The SPSS software package version 16 and EPIDAT were used for
ll calculations and statistical analyses.
esults
According to the 2006 Spanish HIS, a signiﬁcantly higher propor-
ion of women than men  were prescribed analgesics by a doctor
n the two weeks prior to the survey (gender gap 29%), with a
2.1% (6,324) prevalence of pain conﬁrmed by a doctor in women
nd 25.1% (3,632) in men. Moreover, Table 1 shows that more
omen than men  who had been prescribed analgesics suffered pain
gender gap 16.1%). The same sex-difference trends in analgesic
rescription were observed for all age groups (increasing with age),
ocial classes (higher in manual workers), regional levels of gender Ta
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< prob. Men    1    < prob. Women
aOR adjusted by pain confirmed by the doctor, age and social class.
bOR adjusted by pain confirmed by the doctor and age.
cOR adjusted by pain confirmed by the doctor and social class.
dp value < 0.05.
95% confidence intervals.
Source of information: Spanish Health Survey, 2006.
OR 95% IC
Sexa 1,74d (1,59, 1,91)
Social Classb 
Manual 1,85d (1,65, 2,07)
Non Manual 1,52d (1,36, 1,84)
Agec
16 – 44 1,57d (1,37, 1,81)
45 – 64 1,80d (1,55, 2,07)
≥ 65 2,04d (1,66, 2,50)
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.ig. 1. Probability to analgesic prescription in Spanish women compared to men,
ndependently of pain conﬁrmed by the doctor, age and occupation types.
evelopment (higher in regions with a lower GDI) (p <0.001) and
ccording to the type of health care provision (higher for general
ractitioners than specialists) (p <0.001).
The prevalence of pain experienced by women in the 12 months
rior to the survey is higher than in men  in regions with an above
verage gender development index (39.6% of women and 23.5% of
en), and also in regions with a below average gender development
ndex (44.7% of women and 26.6% of men). In Table 1, analgesic pre-
cription data are broken down and presented according to the GDI
f the autonomous regions of residence. The same sex-difference
an be observed for analgesic prescription according to age, social
lass and type of health care provision (general practitioner or spe-
ialist) (p < 0,001).
In regions with a GDI below the Spanish average, pain was more
revalent (35.8%) than in those regions with a higher GDI (31%).
omen  living in lower GDI regions were prescribed analgesics at a
reater rate than those living in regions with a higher GDI, according
o age and social class. The same trend was also observed for men.
t was only in the case of women that differences were detected
n relation to health care provision by a general practitioner or
pecialist, since those who lived in lower GDI regions were more
requently attended by a general practitioner than women  living in
igher GDI regions (p <0.001) (Table 2).
When adjusting for pain conﬁrmed by a doctor, age and social
lass (Fig. 1), there was still a greater probability of analgesic pre-
cription for women than for men, OR = 1.74 (CI95%: 1.59-1.91).
peciﬁcally, this was the case among individuals belonging to the
anual class and for all age groups (Fig. 1). In particular, the prob-
bility of analgesic prescription for women over 65 was twice as
igh as for men.
In Figure 2, these results are broken down and presented accord-
ng to the level of gender development in the area of residence. After
djusting for social class, age and pain, the probability of analgesic
rescription was higher for women than for men  in autonomous
egions with a GDI above (OR = 1.71 [CI95%: 1.51-1.93]) and below
he Spanish average (OR = 1.81 [CI95%: 1.58-2.08]). This difference
an be observed in all social classes and age groups.
It can be seen in Figure 3 that, once adjusted for pain, social
lass and age, women living in regions with a lower level of gen-
er development were more likely to be prescribed analgesics than
hose living in more gender-developed regions OR = 1.26 (CI95%:
.12-1.42). The same pattern can be observed for social class after
djusting for pain and age. There was also a higher probability of
nalgesic prescription among men  living in regions with a lower Ta
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< prob. Men    1    < prob. Women < prob. Men    1    < prob. Women 
GDI lower than the Spanish average GDI higher than the Spanish average 
aOR adjusted by pain confirmed by the doctor, age and social class.
bOR adjusted by pain confirmed by the doctor and age.
cOR adjusted by pain confirmed by the doctor and social class.
dp value < 0.05.
95% confidence intervals.
Source of information: Spanish Health Survey, 2006.      
OR 95% IC
Sexa 1,71d (1,51, 1,93)
Social Classb
Manual 1,75d (1,51, 2,02)
Non 
Manual 1,63
d (1,32, 2,00)
Agec
16 – 44 1,53d (1,27, 1,84)
45 – 64 1,72d (1,40, 2,10)
≥65 2,16d (1,64, 2,84)
OR 95% IC
1,81d (1,58, 2,08)
2,01d (1,69, 2,40)
1,56d (1,25, 1,94)
1,69d (1,35, 2,11)
1,87d (1,51, 2,32)
1,95d (1,44, 2,65)
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hig. 2. Probability to analgesic prescription in women  compared to men  living in Spa
f  pain conﬁrmed by the doctor, age and occupation types.
evel of gender development OR = 1.30 (CI95%: 1.13-1.50), and
mong those from the manual social class.
Table 3 shows that in regions with a lower level of gender devel-
pment, health care (general practitioner, or general practitioner
nd/or specialist) for people experiencing pain varied according to
ex. Regardless of age or social class, women suffering pain are more
ikely than men  to be seen by a general practitioner and not by a
pecialist (OR = 1.32 [CI95%: 1.04-1.67]).
iscussion
Our results show that in Spain, analgesic prescription for men
s frequent (17.3%), but much more so for women (31.4%). Being
 woman and living in regions with a gender development index
elow the Spanish average are two factors that increase the prob-
bility of analgesic prescription. Our results suggest that women
o not receive adequate care or attention for their symptoms and
ealth needs; instead, their symptoms are treated with analgesics,
nd the potential health conditions causing the pain are dismissed
r overlooked, preventing them from being referred to a special-
st and/or receiving the correct treatment. The other signiﬁcant
nding was that, in these regions, women with pain who received
nalgesic prescription were more likely to be seen by a general prac-
itioner alone, whereas men  had a greater chance of being seen by
 specialist. Thus, the main contribution of this study is the analysis
< prob. Higher GDI    1    < pro
Men
aOR adjusted by pain confirmed by the doctor, age and social class.
bOR adjusted by pain confirmed by the doctor and age.
cOR adjusted by pain confirmed by the doctor and social class.
dp value < 0.05.
95% confidence intervals.
Source of information: Spanish Health Survey, 2006.     
OR 95% IC
GDIa 1,30d (1,13, 1,50)
Social Classb 
Manual 1,40d (1,17, 1,68)
Non Manual 1,14 (0,91, 1,43)
Agec
16 – 44 1,60d (1,27, 2,02)
45 – 64 1,27d (1,02, 1,58)
≥65 0,94 (0,70, 1,27)
ig. 3. Probability of analgesic prescription in women and men  living in regions with low
igher  Gender Development Index, independently of pain conﬁrmed by the doctor, age agions with Gender Development Index higher o lower than National, independently
of trends regarding analgesic prescription in Spain from a gender
perspective.
The limitations of this study include the fact that since the Span-
ish Health Survey was  based on self-reports of pain, it is possible
that gender differences as regards reporting behaviour may  explain
some of the sex differences observed in the prevalence of pain, since
women usually report pain with more frequency than men  and
also express quality of pain differently.24 Pain was  measured using
the questions in the Spanish Health Survey about migraine and
chronic pain located in the back and neck. However, other regions
of pain, such as joints, were not included. Nevertheless, the results
of the European Pain Survey about location of pain indicate that the
regions referred to in our study are among the most common.25
Given that the questions speciﬁcally referred to the two
weeks prior to our survey, there was  less probability of mem-
ory bias regarding analgesic prescription, although self-reporting
bias remained a possibility. Nevertheless, the frequency of anal-
gesic prescription would have been even higher if the question had
referred to the previous 12 months, as in the case of pain.26 When
interpreting the results, we did not consider the interval between
the questions regarding analgesic prescription and pain diagnosed
by a doctor, and thus can only assume that the prescription was  in
fact related to the pain diagnosed 12 months previously, as these
questions enquired about chronic pain. A similar situation arises
as regards consultation with a general practitioner or a specialist,
as we do not know whether or not said consultation was  related
b. Lower GDI < prob. Higher GDI    1    < prob. Lower GDI
OR 95% IC
1,26d (1,12, 1,42)
1,28d (1,11, 1,48)
1,24d (1,02, 1,51)
1,46d (1,23, 1,73)
1,14 (0,94, 1,38)
1,07 (0,80,1,42)
Women
er Gender Development Index compared with women  and men  living in areas of
nd occupation types.
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Table 3
Likelihood of being attended by general practitioner versus specialist according to GDI of the area of residence in population with pain and analgesic prescription.
Attended by a general practitioner n (%) Attended by a specialist n (%) OR (CI95%) p ORaa (CI95%) p
Total
Women 1233 (57.6) 857 (42.4) 1.23 (1.04, 1.44) 0.01 1.06 (0.88, 1.26) 0.5
Men 443  (54.0) 378 (46.0)
Living in regions with GDI better than the Spanish average
Women  509 (56.0) 400 (44.0) 1.09 (0.85, 1.39) 0.5 1.80 (0.61, 1.06) 0.1
Men  193 (74.8) 165 (25.2)
Living in regions with GDI worse than the Spanish average
Women 720 (61.3) 455 (38.7) 1.36 (1.09, 1.69) 0.006 1.32 (1.04, 1.67) 0.02
Men 248  (53.9) 212 (46.1)
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wource of information: Spanish National Health Interview Survey 2006.
R: odds ratio; CI95%: conﬁdence interval of 95%.
a Adjusted by age and social class.
o pain or analgesia. In addition, we only analysed prescribed anal-
esics. However, although it might be thought that men  are perhaps
ore likely to self-medicate, a recent study using data from the
panish National Health Survey has shown that men  do not in
act use analgesics without a prescription more frequently than
omen.27 Despite these limitations, the Spanish National Health
urvey has proven to be a valid and widely used tool for estimat-
ng drug prescription patterns. Nevertheless, these ﬁndings require
onﬁrmation by longitudinal studies using methods which explore
otential causal factors.
According to the Spanish Health Survey of 2006, more women
han men  reported pain conﬁrmed by a doctor. This ﬁnding is con-
istent with other studies and is the main factor which determines
nalgesic prescription.28 It is important to draw attention to this
act since it has been observed that analgesic administration is less
nﬂuenced by the discomfort of the person experiencing pain than
y the doctor’s preconceptions about the person in question.3,29 In
ractice, more women are prescribed analgesics than men,29 even
fter adjusting for pain and age. This also remains the case after
djusting for social class, which several studies have shown to be
ssociated with pain and prescription.4,11 This ﬁnding may  indicate
hat analgesic prescription is not merely the logical result of greater
revalence of pain.
Doctors interpret symptoms differently, depending on whether
hese are presented by men  or women.30 Pain is a symptom
elated to a variety of illnesses and can be interpreted differently,
ncluding according to sex, which can lead to different therapeu-
ic approaches.31 There are several gender differences with regard
o aetiology, selected clinical characteristics and association of
ymptoms and signs with coronary heart disease in patients pre-
enting chest pain in a primary care setting.32 This may  translate
nto reduced awareness of the severity of an acute myocardial
nfarction, characterised by precordial pain which appears to be
elated to lower diagnosis rates of the condition before arrival at
he hospital.33 Therefore, doctors’ different interpretations of pain
n women may  lead to inadequate treatment of their symptoms
nd an unsatisfactory response to their health needs.
The reasons given in the literature for higher levels of analgesic
rescriptions to women than men  include assertions that women
re more sensitive to pain, are less tolerant of pain and have a
reater need to report it.5 Perceiving and expressing pain more
han men  may  lead to more prescriptions among women, and with
reater frequency for low level pain, as occurs with other symp-
omatic medicines. However, several studies have demonstrated
hat this might depend on factors related to the doctor, who is
ore prone to offer drugs to female patients than to males with theame symptoms, regardless of gendered preconceptions.24 Conse-
uently, it is important to consider whether this difference implies
 negative effect for women’s health in terms of medicalisation or
hether it is negative for men  in terms of insufﬁcient treatment.Although the adequacy of analgesic prescription was not assessed
in this study, the difference between women and men  was not
explained by differences in prevalence of pain, since our results
were adjusted for pain.
The other main contribution of this study concerns those fac-
tors that inﬂuence analgesic prescription in relation to the level of
gender development in the regions of residence. This ﬁnding has
emerged irrespective of our results regarding individual patient
factors such as sex, social class and age. Thus, in regions with the
lowest GDI in the country, higher rates of analgesic prescription
were found for both sexes. This ﬁnding may  be explained by the
greater prevalence of pain in these regions, coinciding with one of
the few publications which has explored the relationship between
gender development and health –the study Health Behaviour in
School-Aged Children– which demonstrated that women living
in countries with a lower gender development report experienc-
ing certain complaints, such as headaches or abdominal pain,
with more frequency.34 However, the prevalence of pain does not
entirely explain analgesic prescription since, once its effect has
been eliminated, it remains the case that the lower the level of
gender development, the higher the level of analgesic prescription,
and that this is even more pronounced among women.
As regards an explanation for the higher levels of analgesic pre-
scription for women than for men, especially among those women
living in regions with a lower level of gender development, an argu-
ment which has been suggested in other studies may  be pertinent
here, namely, that it is due to a vicious circle of repeated visits at the
same level of health care, with associated lack of access to special-
ist services and restriction to non-speciﬁc, symptomatic treatment
(analgesics).35
The results of this study can be associated with the body of
research which has attempted to demonstrate that illness and
treatment trends reﬂect the economic and political characteristics
of each society and the various forms of social inequality. Gen-
der inequality affects health and gender inequalities in health.36
In this respect, it has been demonstrated that the empower-
ment of women and their participation in political, economic and
social life is associated with lower mortality rates among both
women and men, and with infant well-being.15 Furthermore, it
has been shown that women  can experience problems related
to the equality and quality of health care as regards access to
specialist services,33,37one of the consequences of which is an
increase in the prescription of symptomatic treatment. In relation
to symptomatic treatment such as analgesics, a study in Spain (Cat-
alonia) has shown that in a population with pain, women were
attended more frequently by a general practitioner whereas men
were referred more frequently to hospital.38 This effect has already
been reported for other health problems such as tuberculosis39 or
myocardial infarction.33 These differences in referral are important,
as our review of the literature suggests that specialists are more
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nowledgeable about speciﬁc medical conditions, use more
esources and may  achieve better clinical outcomes.40 Moreover,
 Spanish study found that agreement between general practi-
ioners and specialists regarding diagnosis of pathologies with less
iagnostic criteria was moderate or low.41
This study makes a further contribution to knowledge in this
eld, speciﬁcally that women may  be exposed to a double gender
ias, the ﬁrst deriving from the condition of being a woman and the
econd from the context of lower regional levels of gender devel-
pment, the latter of which also affects men. This study is therefore
mportant as it adds a contextual factor that conditions the treat-
ent of pain, namely, the level of gender development in the area
f residence. These ﬁndings need to be conﬁrmed by longitudi-
al studies using methods which explore potential causal factors.
ender bias may  be one of the pathways by which inequalities in
nalgesic treatment adversely affect women’s health. Moreover,
esearch into the suitability of analgesic treatment and the pos-
ible medicalisation of women should consider contextual factors,
uch as gender development, since these could involve a high price
or women’s health as well as inﬂated pharmaceutical costs in these
imes of economic crisis. In order to prevent gender bias amongst
ealth professionals when treating pain, this issue should form part
f medical school curricula.
What is already known?
It is well known that sex differences in analgesic prescrip-
tion are not merely the logical result of greater prevalence of
pain in women (since this therapeutic variability is related to
factors as educational level or social class).
What this study adds to what was known?
This study adds a contextual factor conditioning treatment
of pain: being a woman and living in areas with lower gen-
der development are two independent determining factors
which increase the likelihood of a physician deciding to pre-
scribe analgesia. In these areas, women experiencing pain are
less likely to be treated by specialists than men. Institutions
conducting clinical practice guidelines and scientiﬁc societies
should take steps to inform physicians about gender inequal-
ities in analgesic prescription; and to place it in guidelines of
medical practice.
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